Profile picture

Professor Francois Mach

University hospitals of Geneva, Geneva (Switzerland)
Membership: ESC Professional Member
Follow
Biography
Prof. François Mach (h index >100), is an expert in the field of development and progression of atherosclerosis diseases. He obtained his MD in internal medicine and cardiology at the University of Geneva. He completed a post-doctoral fellowship in the laboratory of Prof. Peter Libby, Boston (1995-1999). He became full Professor of cardiology in 2000, and was appointed Head of the cardiology department at Geneva University Hospital in 2002. Between 2012-14, he was the President of the Swiss Society of Cardiology. He is the author of more than 500 high impact factor publications and responsible of several Swiss cohorts of atherothrombotic patients, strongly implicated in clinical research in the field of prevention, especially lipidology. He was one of the 3 co-chairs of the ESC 2019 Lipid Guidelines, and co-chaired the ESC 2021 Prevention Guidelines. He is currently co-chairing the 2025 ESC/EAS Focus Lipid guidelines.
Logo ESC

Contributor content

Ask the Trialists - NEWTON-CABG
Session
Ask the Trialists - NEWTON-CABG
1 September 2025
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
Session
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
31 August 2025
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Ask the Task Force
Session
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Ask the Task Force
31 August 2025
Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease
Session
Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease
29 August 2025
Preventing atherosclerotic vascular disease throughout life: the earlier the better
Session
Preventing atherosclerotic vascular disease throughout life: the earlier the better
28 August 2021
Late Breaking Science in Prevention 2
Session
Late Breaking Science in Prevention 2
3 September 2019
2019 ESC/EAS Guidelines on Dyslipidaemias
Session
2019 ESC/EAS Guidelines on Dyslipidaemias
2 September 2019
Meet the Task Force of the 2019 ESC/EAS Guidelines on Dyslipidaemias
Session
Meet the Task Force of the 2019 ESC/EAS Guidelines on Dyslipidaemias
2 September 2019
Professor Braunwald’s perspective on lipid lowering
Session
Professor Braunwald’s perspective on lipid lowering
2 September 2019
Late Breaking Pharmacological Science
Session
Late Breaking Pharmacological Science
25 August 2018

ESC 365 is supported by